p-Cresol sulfate is the dominant component of urinary myelin basic protein like material

Archives of Biochemistry and Biophysics

Volumn 377, Issue 1, 2000, Pages 9-21

  Cao, Ligong ^a,b   Kirk, Marion C ^b,c   Coward, Lori U ^b,c   Jackson, Patricia ^b   Whitaker, John N ^a,b,d  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

HPLC; Mass spectrometry; Multiple sclerosis; Myelin basic protein; Nuclear magnetic resonance spectroscopy; P cresol sulfate; Radioimmunoassay; Urine

Indexed keywords

CRESOL; MYELIN BASIC PROTEIN; SULFATE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; DEMYELINATING DISEASE; FEMALE; HUMAN; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

STAPHYLOCOCCUS PHAGE 187;

EID: 0034194054     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.2000.1764     Document Type: Article

References (35)

1. Campagnoni A. T. J. Biol. Chem. 268:1993;4930-4938.
2. Campagnoni A. T. J. Neurochem. 51:1988;1-14.
3. Moscarello M. A. Hashim G. A., Moscarello M. Dynamic Interactions of Myelin Proteins. 1990;336-348 Wiley, New York.
4. Day E. D., Potter N. T. J. Neuroimmunol. 10:1986;289-312.
5. Whitaker J. N., Chou C. H. J., Chou F. C. H., Kibler R. F. J. Exp. Med. 146:1977;317-331.
6. Lublin F. D., Reingold S. C. Neurology. 46:1996;907-911.
7. Whitaker J. N. Ann. Neurol. 22:1987;648-655.
8. Whitaker J. N. Ann. Neurol. 35:1994;577-585.
9. Whitaker J. N. Ann. Neurol. 38:1995;625-632.
10. Bashir K., Whitaker J. N. Neurology. 53:1999;765-771.
11. Whitaker J. N., Herman P. K. J. Neuroimmunol. 19:1988;47-57.
12. Kurtzke J. F. Neurology. 33:1983;1444-1452.
13. Fowler L. R., Rammler D. H. Biochemistry. 3:1964;230-237.
14. Scommegna A., Bieniary J. J. Clin. Endocrin. Metab. 33:1971;787-792.
15. Coward L., Kirk M., Albin N., Barnes S. Clin. Chim. Acta. 247:1996;121-142.
16. Whitaker J. N., Heinemann M. A., Smith O. F. Neurology. 32:1982;A86.
17. Wasserman E., Levine L. J. Immunol. 87:1961;290-295.
18. Levy G. C., Litcher R. L., Nelson G. Carbon-13 Nuclear Magnetic Resonance Spectroscopy. 1993;Krieger, Malabar.
19. Lambert J. B., Shurvell H. F., Lightner D. A., Cooks R. G. Organic Structural Spectroscopy. 1998;Prentice-Hall, Upper Saddle River.
20. Whitaker J. N., Moscarello M. A., Herman P. K., Epand R. M., Surewicz W. K. J. Neurochem. 55:1990;568-576.
21. Merck Index, 1976, pp, 335, Merck, Rahway, NJ.
22. Geypens B. Gut. 41:1997;70-76.
23. Dills R. L., Bellamy G. M., Kalman D. A. J. Chromatogr. 703:1997;105-113.
24. Falany C. N. FASEB J. 11:1997;206-216.
25. Niehrs C., BeiBwanger R., Huttner W. B. Chem.-Biol. Interact. 92:1994;257-271.
26. Hille A., Huttner W. B. Eur. J. Biochem. 188:1990;587-596.
27. Yagami T., Kitagawa K., Futaki S. Rapid Commun. Mass. Spectrom. 9:1995;1335-1341.
28. Scoble H., Whitaker J. N., Biemann K. J. Neurochem. 47:1986;614-616.
29. Sleeman J. P., Rahmsdorf U., Steffen A., Ponta H., Herrlich P. Eur. J. Biochem. 255:1998;74-80.
30. Lim Y.-C. J. Immunol. 161:1998;2501-2508.
31. Ranasinghe J. G., Sakakibara Y., Nishiyama K., Liu M. C., Suiko M. Biosci. Biotech. Biochem. 63:1999;229-231.
32. Fujinami R. S., Oldstone M. B. A. Science. 230:1985;1043-1045.
33. Hemmer B. J. Exp. Med. 185:1997;1651-1659.
34. Gran B., Hemmer B., Vergelli M., McFarland H. F., Martin R. Ann. Neurol. 45:1999;559-567.
35. von Greyerz S. J. Immunol. 162:1999;595-602.